Fulminant streptococcal infection with early immunoglobulin introduction resulting in a favourable outcome for both mother and new‐born: A case report
Reproductive, Female and Child Health · 2022
DOI: 10.1002/rfc2.14 ↗Kurz gefasst
Fallbericht in der Zeitschrift Reproductive, Female and Child Health, 2022. Verfasst von Takanori Sato und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The antibacterial agent was changed from cefepime to piperacillin and clindamycin for streptococcal toxic shock syndrome, and an emergency cesarean section was performed. Immunoglobulin was added on the first postoperative day. Group A Streptococcus was isolated on the second postoperative day. Case A 37‐year old woman visited her doctor with complaints of sore throat and fever at 32 weeks gestation, she visited her previous doctor for sore throat and fever. She was treated with cefepime and transported to hospital.
Conclusion
Antimicrobial therapy and combined immunoglobulin administration were continued. Both mother and infant survived.
Zitieren
APA
Sato, T., Oyama, R., & Baba, T. (2022). Fulminant streptococcal infection with early immunoglobulin introduction resulting in a favourable outcome for both mother and new‐born: A case report. Reproductive, Female and Child Health. https://doi.org/10.1002/rfc2.14
Vancouver
Sato T, Oyama R, Baba T. Fulminant streptococcal infection with early immunoglobulin introduction resulting in a favourable outcome for both mother and new‐born: A case report. Reproductive, Female and Child Health. 2022. doi:10.1002/rfc2.14
BibTeX
@article{Sato2022,
author = {Sato, Takanori and Oyama, Rie and Baba, Tsukasa},
title = {Fulminant streptococcal infection with early immunoglobulin introduction resulting in a favourable outcome for both mother and new‐born: A case report},
journal = {Reproductive, Female and Child Health},
year = {2022},
doi = {10.1002/rfc2.14}
}
EUVIMED